Cash Flow Statement
Growth Metrics

Elevance Health (ELV) Other financing activities (2016 - 2025)

Elevance Health (ELV) has disclosed Other financing activities for 14 consecutive years, with $12.0 million as the latest value for Q4 2025.

  • Quarterly Other financing activities rose 271.43% to $12.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $22.0 million through Dec 2025, up 1000.0% year-over-year, with the annual reading at $22.0 million for FY2025, 1000.0% up from the prior year.
  • Other financing activities for Q4 2025 was $12.0 million at Elevance Health, down from $21.0 million in the prior quarter.
  • The five-year high for Other financing activities was $171.0 million in Q1 2021, with the low at -$160.0 million in Q2 2021.
  • Average Other financing activities over 5 years is $5.2 million, with a median of $4.0 million recorded in 2024.
  • The sharpest move saw Other financing activities tumbled 450.0% in 2024, then surged 2000.0% in 2025.
  • Over 5 years, Other financing activities stood at $19.0 million in 2021, then skyrocketed by 31.58% to $25.0 million in 2022, then tumbled by 92.0% to $2.0 million in 2023, then crashed by 450.0% to -$7.0 million in 2024, then soared by 271.43% to $12.0 million in 2025.
  • According to Business Quant data, Other financing activities over the past three periods came in at $12.0 million, $21.0 million, and $3.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.